Similar outcome of heart failure with reduced EF patients with and without atrial fibrillation: considerations from the ESC Heart Failure Long-Term Registry

Main Article Content

Renato De Vecchis *
(*) Corresponding Author:
Renato De Vecchis | devecchis.erre@virgilio.it

Abstract

Recently, transcatheter ablation of atrial fibrillation (AF) has been validated by international societal guidelines as a technique suitable for both treatment and secondary prevention of paroxysmal, persistent or long-lasting persistent AF in highly symptomatic patients in whom at least one antiarrhythmic drug had been tested.


Downloads month by month

Downloads

Download data is not yet available.

Article Details